DK1353726T3 - Rehydreringssammensætninger - Google Patents

Rehydreringssammensætninger

Info

Publication number
DK1353726T3
DK1353726T3 DK02711526T DK02711526T DK1353726T3 DK 1353726 T3 DK1353726 T3 DK 1353726T3 DK 02711526 T DK02711526 T DK 02711526T DK 02711526 T DK02711526 T DK 02711526T DK 1353726 T3 DK1353726 T3 DK 1353726T3
Authority
DK
Denmark
Prior art keywords
fluid
rehydration
relates
dietetic
carbohydrates
Prior art date
Application number
DK02711526T
Other languages
Danish (da)
English (en)
Inventor
Robert Johan Joseph Hageman
George Verlaan
Rudolf Leonardus Lodewi Smeets
Original Assignee
Nutricia Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nutricia Nv filed Critical Nutricia Nv
Application granted granted Critical
Publication of DK1353726T3 publication Critical patent/DK1353726T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
    • A23L2/38—Other non-alcoholic beverages
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
DK02711526T 2001-01-26 2002-01-28 Rehydreringssammensætninger DK1353726T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/770,773 US20020176881A1 (en) 2001-01-26 2001-01-26 Rehydration composition
PCT/NL2002/000063 WO2002058792A2 (fr) 2001-01-26 2002-01-28 Composition de rehydratation

Publications (1)

Publication Number Publication Date
DK1353726T3 true DK1353726T3 (da) 2007-10-15

Family

ID=25089632

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02711526T DK1353726T3 (da) 2001-01-26 2002-01-28 Rehydreringssammensætninger

Country Status (9)

Country Link
US (3) US20020176881A1 (fr)
EP (2) EP1353726B1 (fr)
AT (2) ATE364328T1 (fr)
AU (1) AU2002230270B2 (fr)
CA (1) CA2436764C (fr)
DE (1) DE60220640T2 (fr)
DK (1) DK1353726T3 (fr)
ES (1) ES2286238T3 (fr)
WO (1) WO2002058792A2 (fr)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7740878B2 (en) * 2001-10-22 2010-06-22 Danisco A/S Use of betaine to enhance exercise performance
DE10214168A1 (de) * 2002-03-27 2003-10-09 Siegfried Irion Coffeinhaltiges Getränkeerzeugnis
US7850989B2 (en) * 2003-06-12 2010-12-14 Provimi North America, Inc. Critical care for neonatal calves
DE20312929U1 (de) * 2003-08-18 2003-10-23 Donhuysen, Sven, 47800 Krefeld Energiegetränk
US7527816B2 (en) * 2004-08-06 2009-05-05 Techmix, Inc. Feed supplement and method
FR2913338B1 (fr) * 2007-03-06 2009-07-24 Aditec Soc Par Actions Simplif Composition de rehydratation.
US8466187B2 (en) 2007-09-18 2013-06-18 Thermolife International, Llc Amino acid compositions
US8187647B2 (en) 2008-06-13 2012-05-29 BioClinical Development, Inc. Edible energy composition
WO2009065119A2 (fr) * 2007-11-16 2009-05-22 Bio Clinical Development, Inc. Composition énergétique comestible à faible teneur en caféine
US9017748B2 (en) * 2007-12-28 2015-04-28 Kraft Foods Group Brands Llc Potassium fortification in foodstuffs
EP2098124A1 (fr) 2008-03-03 2009-09-09 Nestec S.A. Gel de glucide
US20090286750A1 (en) * 2008-05-16 2009-11-19 Kasubick Robert V Use of ribose in lessening the clinical symptoms of aberrant firing of neurons
CA2723441A1 (fr) * 2008-05-21 2009-11-26 Stokely-Van Camp, Inc. Boisson de recuperation a base de lait
US9049879B2 (en) 2008-06-13 2015-06-09 International Ip Holdings Llc Edible energy composition
US10881661B2 (en) 2008-06-13 2021-01-05 International Ip Holdings Llc Edible energy composition
EP2461707A4 (fr) * 2009-08-04 2013-08-28 Northforce Oy Composition de boisson
AU2012242565B2 (en) 2011-04-13 2017-05-11 Thermolife International, Llc N-Acetyl Beta Alanine methods of use
US8557301B2 (en) 2011-07-01 2013-10-15 Drip Drop, Inc. Oral rehydration composition
JP5695688B2 (ja) * 2013-03-08 2015-04-08 サントリー食品インターナショナル株式会社 飲料
US10653168B2 (en) 2013-06-12 2020-05-19 Sweetwater Solutions, LLC Oral rehydration solution with improved taste
US20180064154A9 (en) * 2015-09-01 2018-03-08 D. Holmes Morton Management of propionate metabolism disorders
US20170360074A1 (en) * 2016-06-17 2017-12-21 Krampade, LLC Consumable electrolyte compositions and methods of use thereof
CN106071540A (zh) * 2016-06-17 2016-11-09 山东祥维斯生物科技股份有限公司 运动型保健减肥饮料及其制备方法
US11197917B2 (en) 2017-12-01 2021-12-14 ByHeart, Inc. Formulations for nutritional support in subjects in need thereof
US10820617B1 (en) 2018-03-29 2020-11-03 Government Of The United States, As Represented By The Secretary Of The Air Force All inclusive electrolytes, vitamins, and protein powder training supplement
US20210299166A1 (en) * 2020-03-25 2021-09-30 Allgood Beverage Company Compositions for maintaining electrolyte balance and urinary tract health
US12156886B2 (en) 2020-11-12 2024-12-03 Thermolife International, Llc Methods of increasing blood oxygen saturation
US11865139B2 (en) 2020-11-12 2024-01-09 Thermolife International, Llc Method of treating migraines and headaches
MX2023009015A (es) 2021-02-11 2023-08-08 Thermolife Int Llc Un metodo para administrar gas de oxido nitrico.
US20220306975A1 (en) * 2021-03-29 2022-09-29 Jho Intellectual Property Holdings, Llc Electrolyte-containing alcoholic beverages
WO2025183662A1 (fr) * 2024-02-26 2025-09-04 Kozlovskyi Vadym Oleksiiovych Solution électrolytique
US12440512B1 (en) * 2024-12-08 2025-10-14 Iv Nector Md Systems and methods for preparing and administering a hydrating supplement composition

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE427983B (sv) * 1980-02-15 1983-05-30 Pripps Bryggerier Ab Dryckesprodukt
US4631189A (en) * 1980-03-10 1986-12-23 Da Vinci Laboratories, a division of FoodScience Corporation N,N-dimethylglycine and use in immune response
US5017389A (en) * 1988-08-16 1991-05-21 Green Scott T Nutritional drink compositions
US5114723A (en) 1990-02-27 1992-05-19 University Of Texas System Board Of Regents Beverage compositions for human consumption
US5032411A (en) * 1990-02-27 1991-07-16 University Of Texas System Board Of Regents Beverage compositions for human consumption
US5182299A (en) * 1990-03-19 1993-01-26 Brigham And Women's Hospital Treatment of osmotic disturbance with organic osmolytes
WO1991014435A1 (fr) * 1990-03-19 1991-10-03 Brigham And Women's Hospital Traitement de troubles osmotiques a l'aide d'osmolytes organiques
US5292538A (en) * 1992-07-22 1994-03-08 Metagenics, Inc. Improved sustained energy and anabolic composition and method of making
US5498408A (en) * 1992-09-21 1996-03-12 Sandoz Nutrition Ltd. Oral rehydration composition
US5397786A (en) * 1993-01-08 1995-03-14 Simone; Charles B. Rehydration drink
US5389383A (en) * 1993-06-18 1995-02-14 Allergan, Inc. Method for treating hypoxia-associated ocular complications
US5464619A (en) * 1994-06-03 1995-11-07 The Procter & Gamble Company Beverage compositions containing green tea solids, electrolytes and carbohydrates to provide improved cellular hydration and drinkability
US5580856A (en) * 1994-07-15 1996-12-03 Prestrelski; Steven J. Formulation of a reconstituted protein, and method and kit for the production thereof
AU3570495A (en) * 1994-09-22 1996-04-09 Quadrant Holdings Cambridge Limited Compositions for use in rehydration and nutrition during athletic exercise and methods of making same
US6020139A (en) * 1995-04-25 2000-02-01 Oridigm Corporation S-adenosyl methionine regulation of metabolic pathways and its use in diagnosis and therapy
EP0875155A1 (fr) 1997-05-01 1998-11-04 N.V. Nutricia Boisson périoperatif
EP0891719A1 (fr) * 1997-07-14 1999-01-20 N.V. Nutricia Composition dietique contenant de la methionine
GB9715340D0 (en) * 1997-07-22 1997-09-24 Cerestar Holding Bv Beverages for enhanced physical performance
US5972985A (en) * 1997-11-03 1999-10-26 Cytos Pharmaceuticals, Llc Histidine containing nutriceutical compositions
US5891888A (en) * 1998-01-14 1999-04-06 Strahl; Robert Charles Physical endurance drink
WO2000025793A1 (fr) * 1998-10-30 2000-05-11 Merck Patent Gmbh Composition de traitement et de prevention de troubles neurologiques et psychopathologiques
US6420342B1 (en) * 2000-05-08 2002-07-16 N.V. Nutricia Nutritional preparation comprising ribose and medical use thereof
US20030099722A1 (en) * 2001-10-09 2003-05-29 Baxter Jeffrey H. Methods and compositions for providing glutamine
US8697679B2 (en) * 2003-03-07 2014-04-15 N.V. Nutricia Method and composition for treating or preventing catabolism or stimulating anabolism in a mammal undergoing metabolic stress

Also Published As

Publication number Publication date
WO2002058792A8 (fr) 2003-11-06
AU2002230270B2 (en) 2006-05-04
CA2436764C (fr) 2011-03-29
ATE364328T1 (de) 2007-07-15
ATE551911T1 (de) 2012-04-15
US20040087518A1 (en) 2004-05-06
US7375089B2 (en) 2008-05-20
US20080193589A1 (en) 2008-08-14
ES2286238T3 (es) 2007-12-01
CA2436764A1 (fr) 2002-08-01
EP1353726B1 (fr) 2007-06-13
US20020176881A1 (en) 2002-11-28
WO2002058792A3 (fr) 2002-11-21
WO2002058792A2 (fr) 2002-08-01
EP1762271B1 (fr) 2012-04-04
EP1762271A2 (fr) 2007-03-14
EP1353726A2 (fr) 2003-10-22
EP1762271A3 (fr) 2007-06-27
DE60220640T2 (de) 2008-02-21
DE60220640D1 (de) 2007-07-26

Similar Documents

Publication Publication Date Title
DK1353726T3 (da) Rehydreringssammensætninger
DK1364107T3 (da) Hydraulisk fraktureringsvæske indeholdende en blokcopolymer med mindst én vandopløselig blok og én hydrofob blok
DE60219631D1 (de) Absorbierender artikel mit grössenanpassung
BRPI0207215B8 (pt) Derivados de pirazolopirimidinona tendo ação de inibição de pde7
CY1109528T1 (el) Μεθοδος και συσκευη για εξωτερικη σταθεροποιηση καρδιας
DK1988397T3 (da) Præparater og anvendelser til stabilisering af transthyretin og inhibering af transthyretin-fejlfoldning
MXPA04004347A (es) Nuevos fotoindicadores difuncionales.
BR9916272A (pt) 4 e 5-alquiniloxindóis e 4 e 5-alqueniloxindóis
TR200502508T2 (tr) IL-18 İnhibitörlerinin kullanımı.
ATE496109T1 (de) Umsetzungsprodukte von mercaptobenzothiazolen, mercaptothiazolinen und mercaptobenzimidazolen mit epoxiden als schmiermitteladditive
ATE317706T1 (de) Tocopherol-haltige superabsorber
BR0208694A (pt) Uso de inibidores de cox-2 seletivos para tratamento de incontinência urinária
BR0209541A (pt) Uso das imidazotriazinonas 2-fenil-substituìdas
DE602004015169D1 (de) Kleinkindernahrung mit proteasehemmer
MXPA05001885A (es) El uso de una combinacion de ciclesonida y antihistaminas para el tratamiento de la rinitis alergica.
DK1269859T3 (da) Anvendelse af middelkædede triglycerider til forebyggelse og terapi af adipositas
HUP0400520A2 (hu) Klindamicint és cinksót tartalmazó dermatológiai készítmények
MX9403032A (es) Quinolil-dihidropiridinas condensadas, procedimiento para su fabricacion ysu uso en medicamentos.
MXPA03000313A (es) Uso de fosfato de estramustina en el tratamiento de metastasis osea.
ES2194763T3 (es) Jeringuilla.
DE60325744D1 (de) Zubereitung zur behandlung des nasopharyngalen carcinom und verwendung derselben
CY1107343T1 (el) ΕΝΑ ΠΡΟΪΟΝ ΣΥΝΔΥΑΣΜΟΥ ΠΟΥ ΠEPΙΛΑΜΒΑΝΕΙ ΜΕΛΑΓΑΤΡΑΝΗ ΚΑΙ ΕΝΑΝ ΑΝΑΣΤΟΛΕΑ ΠΑΡΑΓΟΝΤΑ VIIa
RU2003101786A (ru) Мазь "гидропент" для лечения инфицированных ран
ATE289513T1 (de) Verwendung eines phosphatadsorbers gegen gefässerkrankungen
ES2196802T3 (es) Lactatos de citronelilo y/o de dihidrocitronelilo, su preparacion y su utilizacion.